KCM
SGYP

Kingdon Capital Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Kingdon Capital Management’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-649,000
Closed -$2.89M – 149
2017
Q2 		$2.89M Buy
+649,000
New +$2.68M 0.2% 79
2015
Q3 		– Sell
-200,000
Closed -$1.66M – 169
2015
Q2 		$1.66M Buy
+200,000
New +$969K 0.06% 124

Other funds holding SGYP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Kingdon Capital Management's SGYP Position: Q4 2018 in Review

Kingdon Capital Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 1,403,149 shares — an estimated $2.38M sold.

Kingdon Capital Management first reported a position in SGYP in Q3 2015 and held it in 12 quarters. The position peaked at $10.4M in Q1 2017. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

  • Kingdon Capital Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
  • Kingdon Capital Management sold 1,403,149 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $2.38M.
  • Kingdon Capital Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2015 and held it in 12 quarters.
  • Kingdon Capital Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $10.4M in Q1 2017.
  • 89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Kingdon Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.